Entries by actualizedevs

NCCS Submits Comments in Follow-Up to FDA Patient-Focused Public Meeting

/in , , , ,

NCCS submitted comments to the Food and Drug Administration (FDA) as a follow-up to the Lung Cancer Patient-Focused Drug Development public meeting on June 28, 2013. The patient-focused drug development program is an initiative mandated by the Food and Drug Administration Safety and Innovation Act (FDASIA) and is intended to provide the agency the advice of patients […]

NCCS Joins Patient Advocate Colleagues in Commenting on FDA Document on Expedited Programs for Serious Conditions

/in , , ,

NCCS joined its patient advocate colleagues in the Cancer Leadership Council in comments on a Food and Drug Administration (FDA) document that provides guidance about the use of certain “expedited programs” that may be employed in the review of therapies for serious conditions.  The FDA has updated the guidance regarding fast track and priority review […]

NCCS Announces Special Event — How Does the Media Impact Perceptions of Cancer and Cancer Care?

/in

The media — broadcast, social media, print, or blogs — can have a transformative influence on  how cancer patients and their families receive information about their disease, navigate difficult choices about treatment, and make decisions about their lives after cancer. This year, NCCS will host a special panel discussion about how cancer is covered in media and entertainment, […]

IOM Releases “Partnering with Patients” Meeting Summary

/in ,

The Institute of Medicine released a meeting summary today of a workshop that took place in February, “Partnering with Patients to Drive Shared Decisions, Better Value, and Care Improvements.” A short video capturing the key messages of the workshop, and including the voice of patients, has also been released. In an efficient health care system, […]

JAMA Opinion Piece: The Short and Long Term Implications of Myriad Decision

/in ,

On June 13, 2013, the Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics that a human gene removed from the body and unchanged from its natural form cannot be patented.   Cancer advocates greeted the ruling with enthusiasm and also hoped that the ruling would have the impact of creating more competition for […]

The Definition of “Cancer”: JAMA Opinion Piece Triggers Medical, Scientific, and Policy Debate

/in ,

With the online publication of an opinion piece in the Journal of the American Medical Association, Drs. Laura J. Esserman, Ian M. Thompson, and Brian Reid have triggered a medical, scientific, and policy debate about the definition of “cancer” and strategies for diagnosis and treating cancer.  The authors wrote for a working group that was […]

NCCS Comments on Quality Measures for PPS-Exempt Cancer Hospitals

/in , , , ,

NCCS filed comments in support of proposed cancer care quality measures that will be utilized to assess the cancer care provided by the prospective payment system (PPS)-exempt cancer hospitals.  In its comments, NCCS focused on the outcome measure that will assess the performance of PPS-exempt institutions in preventing inpatient admission or emergency department care for […]